M Jones

Summary

Affiliation: University of Edinburgh
Country: UK

Publications

  1. ncbi In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc
    M Jones
    National CJD Surveillance Unit, School of Molecular and Clinical Medicine Pathology, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK
    J Pathol 213:21-6. 2007
  2. ncbi Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development
    R W Pelton
    Department of Cell Biology, Vanderbilt University Medical School, Nashville, Tennessee 37232
    J Cell Biol 115:1091-105. 1991
  3. ncbi Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
    S Tedoldi
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
    J Pathol 209:454-63. 2006
  4. ncbi Genes other than TLR4 are involved in the response to inhaled LPS
    E Lorenz
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Am J Physiol Lung Cell Mol Physiol 281:L1106-14. 2001
  5. ncbi Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continents
    S Kösel
    Department of Neuropathology, Imperial College School of Medicine, London, UK
    Neurogenetics 3:163-70. 2001
  6. ncbi Protein dynamics enhance electronic coupling in electron transfer complexes
    K K Chohan
    Department of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom
    J Biol Chem 276:34142-7. 2001
  7. ncbi Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules
    H T Moins-Teisserenc
    Nuffield Department of Medicine, Institute of Molecular Medicine, Oxford, UK
    Lancet 354:1598-603. 1999
  8. ncbi Lymphocyte-specific protein 1: a specific marker of human leucocytes
    K Pulford
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Biochemistry and Cellular Science, John Radcliffe Hospital, Oxford, UK
    Immunology 96:262-71. 1999
  9. ncbi Mismatch repair of deaminated 5-methyl-cytosine
    M Jones
    J Mol Biol 194:155-9. 1987
  10. ncbi SLCO1B1 variants and statin-induced myopathy--a genomewide study
    E Link
    N Engl J Med 359:789-99. 2008

Collaborators

Detail Information

Publications10

  1. ncbi In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc
    M Jones
    National CJD Surveillance Unit, School of Molecular and Clinical Medicine Pathology, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK
    J Pathol 213:21-6. 2007
    ....
  2. ncbi Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development
    R W Pelton
    Department of Cell Biology, Vanderbilt University Medical School, Nashville, Tennessee 37232
    J Cell Biol 115:1091-105. 1991
    ..This also indicates that TGF beta 1, beta 2, and beta 3 act through both paracrine and autocrine mechanisms during mammalian embryogenesis...
  3. ncbi Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
    S Tedoldi
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
    J Pathol 209:454-63. 2006
    ..Finally, the expression of Jaw1/LRMP in other types of lymphoma and in non-lymphoid tissues/tumours may be of interest in differential diagnosis and research...
  4. ncbi Genes other than TLR4 are involved in the response to inhaled LPS
    E Lorenz
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Am J Physiol Lung Cell Mol Physiol 281:L1106-14. 2001
    ....
  5. ncbi Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continents
    S Kösel
    Department of Neuropathology, Imperial College School of Medicine, London, UK
    Neurogenetics 3:163-70. 2001
    ....
  6. ncbi Protein dynamics enhance electronic coupling in electron transfer complexes
    K K Chohan
    Department of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom
    J Biol Chem 276:34142-7. 2001
    ..Domain motion establishes a new "robust engineering principle" for electron transfer complexes, tolerating multiple configurations of the complex while retaining efficient electron transfer...
  7. ncbi Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules
    H T Moins-Teisserenc
    Nuffield Department of Medicine, Institute of Molecular Medicine, Oxford, UK
    Lancet 354:1598-603. 1999
    ..We present evidence for a new aetiology for chronic granulomatous lesions associated with a recessive genetic defect, which is linked to the human leucocyte antigen (HLA) locus...
  8. ncbi Lymphocyte-specific protein 1: a specific marker of human leucocytes
    K Pulford
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Biochemistry and Cellular Science, John Radcliffe Hospital, Oxford, UK
    Immunology 96:262-71. 1999
    ..As the anti-LSP1 reagent used in the present study recognizes a formalin-resistant epitope it should be of considerable value in the diagnosis of routinely fixed material...
  9. ncbi Mismatch repair of deaminated 5-methyl-cytosine
    M Jones
    J Mol Biol 194:155-9. 1987
    ..coli dcm methylase and some, but not all, of the functions of the E. coli methyl-directed mismatch repair system. The repair appears to act only on the G-T mismatch and acts specifically to restore the cytosine methylation sequence...
  10. ncbi SLCO1B1 variants and statin-induced myopathy--a genomewide study
    E Link
    N Engl J Med 359:789-99. 2008
    ..Genotyping these variants may help to achieve the benefits of statin therapy more safely and effectively. (Current Controlled Trials number, ISRCTN74348595.)..